Takeda Oncology
Swarna Mehrotra PhD, MBA, currently serves as Associate Director and Global Marketing Lead at Takeda Oncology, a position held since July 2021, alongside roles in Strategy & Business Operations and Global Oncology Insights & Analytics. Prior experience includes working as a Strategy & Insights Consultant at ZS from July 2019 to July 2021 and a Summer Associate at Outcome Capital in summer 2018. Additionally, Swarna held positions as a Venture Associate and Licensing Intern at the University of Virginia Licensing & Ventures Group from November 2017 to May 2017. Prior to this, experience as a Postdoctoral Research Associate at the Robert H. Lurie Cancer Center spanned from July 2012 to August 2015. Educational credentials include an MBA from the University of Virginia Darden School of Business, a Ph.D. in Cancer Biology from UMass Chan Medical School, and a B.S/M.S in Human Biology/Biochemistry from the All India Institute of Medical Sciences.
This person is not in any teams
This person is not in any offices
Takeda Oncology
20 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.